U.S.
-
Recon
Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies
WILMINGTON, DE, Sept. 09, 2024 (GLOBE NEWSWIRE) — Enovis™ (NYSE: ENOV), an innovation-driven medical technology growth company, is pleased to…
Read More » -
Extremities
Bioretec reports successful clinical outcomes from U.S. controlled launch of RemeOs™ trauma screw: fracture healing confirmed in 100% of surgical procedures
TAMPERE, Finland, June 19, 2024 /PRNewswire/ — Bioretec Ltd., a pioneer in biodegradable orthopedic implants, is pleased to announce that a number of…
Read More » -
Biologics
5,000 patients treated with OssDsign Catalyst® in the U.S.
Uppsala, May 30, 2024. Today, OssDsign AB (publ.) announces that the company continues its successful penetration of the U.S. orthobiologics…
Read More » -
Sports Medicine
ABANZA Strengthens US Operations with Established Orthopedic Industry Expert, John Rizzo, as Executive Vice President
NAVARRA, Spain, Jan. 22, 2024 /PRNewswire/ — ABANZA is excited and honored to announce the strategic addition of Executive Vice President for US operations, JOHN…
Read More » -
Spine
Spine Pain Industry Analysis in United States Revenue to Total US$ 10,962.7 Million by 2033 amid Rising Prevalence of Back Pain: Future Market Insights, Inc.
The increasing incidence of back pain in the United States is a key driver fueling demand for various treatment options.…
Read More » -
Regulatory
Stratus® Medical adds fifth U.S. patent and two Canadian patents to its 29-patent global IP portfolio for the NIMBUS® Electrosurgical RF Multitined Expandable Electrode
MAGNOLIA, Texas, Nov. 8, 2023 /PRNewswire/ — Stratus® Medical, a company focused on improving clinical outcomes for chronic pain patients by advancing radiofrequency…
Read More » -
Biologics
DiscGenics Announces Research Collaboration with the U.S. Department of Veterans Affairs for Tissue-Engineered Discs with Discogenic Cells
Feasibility Project Awarded VA Technology Transfer Program BRAVE Funding SALT LAKE CITY, Oct. 18, 2023 /PRNewswire/ — DiscGenics, Inc., a privately held, late-stage…
Read More » -
Biologics
2,000 patients treated with OssDsign® Catalyst in the U.S.
Uppsala, September 13, 2023. OssDsign AB (publ.) today announces that the company’s orthobiologic business continues to accelerate its successful commercialization…
Read More » -
Extremities
Inside information: Bioretec enters into the U.S. distribution agreement with Spartan Medical for the RemeOs™ screws
TAMPERE, Finland, Sept. 12, 2023 /PRNewswire/ — Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopedic implants, has signed a distribution…
Read More »